GLOBEALERT
HEALTHLOWSep 2 · Sep 2, 2026, 11:34 AM

Teva posts mid-stage trial win for celiac disease therapy developed with Royalty Pharma

Seeking Alpha Tech · global

Teva achieved a successful mid-stage clinical trial result for a celiac disease therapy developed in partnership with Royalty Pharma. This indicates progress in treating the condition.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More in Health